Skip to main content

XDx s AlloMap and NimbleGen s Microbial Whole-Genome Resequencing Technology

Premium

XDx last week launched AlloMap, a molecular expression profiling test capable of predicting patient outcomes following heart transplantation, the company said in a statement. The test "has a high negative predictive value" for heart transplant rejection, guiding treatment with anti-rejection drugs and reducing problem biopsies, XDx said.


NimbleGen this week introduced its Microbial Whole-Genome Resequencing Technology, which "surveys an entire microbial genome to pinpoint genetic changes" to the SNP level, the company said in a statement.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.